McNeil Consumer Healthcare is recalling certain lots of children’s and infants’ liquid Tylenol manufactured between April and June 2008. According to the company the recall is due to “an unused portion of one inactive ingredient did not meet all quality standards.” The recall does not apply to children’s Tylenol meltaways or junior strength Tylenol meltaways. [...]
If for some reason you need to take pharmaceutical drugs, protect yourself and loved ones by reading the package inserts. According to this research adverse drug events happen to the the tune of $3.5 billion dollars, and those are the reported incidents. The new Food and Drug Administration drug package insert: implications for patient safety [...]
Almost one-quarter of biologic therapies approved in the United States and Europe since 1995 have been the subject of at least one safety-related regulatory action in the decade since they were approved. Eleven percent, including Remicade (infliximab), used to treat Crohn’s disease and rheumatoid arthritis, and Avastin (bevacizumab), used to treat cancer, have been issued [...]
